<body> <div class="logo" align="center"><a href="http://frndzcloud.com"><img src="" alt="火狐体育" title="火狐体育"></a></div>

火狐体育官方网站zuoyiluojiashan,huanraodonghushui,lvshuchengyin,huaxiangliuyi。xuebuyuanyu1943nianchenglidehubeishengshengliyixueyuan,xianzaishi火狐体育liudaxuebuzhiyi。 xuebuhanjichuyixueyuan、diyilinchuangxueyuan、dierlinchuangxueyuan、kouqiangyixueyuan、yaoxueyuan、jiankangxueyuan、zhiyejishuxueyuan...

地址: 湖北省武汉市武昌区东湖路115号
电话:027-68759364
中国科学院院士: 邓子新舒红兵
国家级教学名师: 樊明文边专
国家杰出青年基金获得者: 邓子新舒红兵章晓联李红良卿国良
百千万人才工程选者: 舒红兵、黄从新章晓联 
万人计划: 领军人才:舒红兵唐其柱李红良      
教育部新世纪优秀人才: 章晓联、何小华乐江、 于红刚 李雁郑芳、
胡锦跃、 黄鹤、李红良、 张 旗、 叶晓茜、 尚政军、 郭继华、 张玉峰、
周海兵、 刘天罡、 王连荣、 瞿旭东、洪 葵

undefined

姓名:李红良

单位:火狐体育基础医学院

职称:院长、教授、博导

邮箱:lihl@frndzcloud.com

联系电话:027-68759302

研究方向:

1.xinxueguandaixiexingjibingdefashengjizhiyufangzhi;yanjiumianyijizhi、xinhaochuandaotongluzaixinxueguandaixiexingjibingfashengfazhanzhongdezuoyongjiqijizhi。

2.shengwuyixuegongcheng:jiyinqiaochujizhuanjiyindongwumoxingdegoujian。

 








代表性论著:

1.zhao gn, zhang p, gong j, zhang xj, wang px, jiang z, shen lj, ji yx, tong jj, wang yt, wei qf, wang y, zhu xy, zhang x, fang j, she zg, wang zh, huang z, li h*, tmbim1 protects against nonalcoholic steatohepatitis in mice and monkeys by targeting tlr4 for lysosomal degradation, nat med., 2017 ;23(6):742-752.

2.wang px, ji yx, zhang xj, zhao lp, yan zz, zhang p, shen lj, yang x, fang j, tian s, zhu xy, gong j, zhang x, wei qf, wang y, li j, wan l, xie qg, she zg, wang zh, huang z, li h*, targeting casp8 and fadd-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates, nat med.2017;23(4):439-449.

3.wang zh, zhang xj, zhang p, wang xh, chen i, gao c, deng kq, gong j, yokota t, wang h, cass a, ren sx, vondriska t, li gp, yang ht, xiao xs, li h*, wang y*, a long non- coding rna defines an epigenetic check point for cardiac hypertrophy. nat med. 2016 ,22(10):1131-1139.

4.wang p, zhang x, luo p, jiang x, zhang p, guo j, zhao g, zhu x, zhang y, yang s and li h*. hepatocyte traf3 promotes liver steatosis and systemic insulin resistance through targeting tak1-dependent signalling. nat commun. 2016; 7:10592.

5.ji y, zhang p, zhang x, zhao y, deng k, jiang x, wang p, huang z and li h*. the ubiquitin e3 ligase traf6 exacerbates pathological cardiac hypertrophy via tak1-dependent signalling. nat commun. 2016; 7:11267.

6.deng k, wang a, ji y, zhang x, fang j, zhang y, zhang p, jiang x, gao l, zhu x, zhao y, gao l, yang q, zhu x, wei x, pu j and li h*. suppressor of ikkɛ is an essential negative regulator of pathological cardiac hypertrophy. nat commun. 2016; 7:11432.

7.zhang s, zhu l, chen h, zhang r, zhang p, jiang d, gao l, tian s, wang l, zhang y, wang p, zhang x, zhang x, liu d and li h*. interferon regulatory factor 9 is critical for neointima formation following vascular injury. nat commun. 2014; 5:5160.

8.jiang d, wei x, zhang x, liu y, zhang y, chen k, gao l, zhou h, zhu x, liu pp, bond lau w, ma x, zou y, zhang x, fan g and li h*. irf8 suppresses pathological cardiac remodelling by inhibiting calcineurinsignalling. nat commun. 2014; 5:3303.

9.lu y, li z, jiang d, wang l, zhang y, chen k, zhang x, liu y, fan g, chen y, yang q, zhou y, zhang x, liu d and li h*. traf1 is a critical regulator of cerebral ischaemia–reperfusion injury and neuronal death. nat commun. 2013; 4:2852.

10.xiang m, wang p, wang a, zhang x, zhang y, zhang p, mei f, chen m and li h*. targeting hepatic traf1-ask1 signaling to improve inflammation, insulin resistance, and hepatic steatosis. j hepatol. 2016; 64:1365-1377.

11.hu j, zhu x, zhang x, wang p, zhang r, zhang p, zhao g, gao l, zhang x, tian s and li h*. targeting traf3 signaling protects against hepatic ischemia/reperfusions injury. j hepatol. 2016; 64:146-159.

12.gao l, wang p, zhang y, yu c, ji y, wang x, zhang p, jiang x, jin h, huang z, zhang z and li h*. tumor necrosis factor receptor-associated factor 5 (traf5) acts as an essential negative regulator of hepatic steatosis. j hepatol. 2016;65:125-36.

13.wang p, zhang r, huang l, zhu l, jiang d, chen h, zhang y, tian s, zhang x, zhang x, liu d and li h*. interferon regulatory factor 9 is a key mediator of hepatic ischemia/reperfusion injury. j hepatol. 2015; 62:111-120.

14.zhu l, wang a, luo p, wang x, jiang d, deng w, zhang x, wang t, liu y, gao l, zhang s, zhang x, zhang j and li h*. mindin/spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice. j hepatol. 2014; 60:1046-1054.

15.yan fj, zhang xj, wang wx, ji yx, wang px, yang y, gong j, shen lj, zhu xy, huang z, li h*. the e3 ligase trim8 targets tak1 to promote insulin resistance and steatohepatitis. hepatology. 2017;65(5):1492-1511.

16.wang x, zhang r, she z, zhang x, jiang d, wang t, gao l, deng w, zhang s, zhu l, guo s, chen k, zhang x, liu d and li h*. interferon regulatory factor 3 constrains ikkβ/nf-κb signaling to alleviate hepatic steatosis and insulin resistance. hepatology. 2014; 59:870-885.

17.zhang y, zhang xj, wang px, zhang p, li h*.reprogramming innate immune signaling in cardiometabolic disease. hypertension. 2017;69(5):747-760.

18.zhu x, fang j, gong j, guo j, zhao g, ji y, liu h, wei x and li h*. cardiac-specific epi64c blunts pressure overload–induced cardiac hypertrophynovelty and significance. hypertension. 2016; 67:866-877.

19.gong j, li z, guo s, zhang x, zhang p, zhao g, gao l, zhang y, zheng a, zhang x, xiang m and li h*. neuron-specific tumor necrosis factor receptor–associated factor 3 is a central regulator of neuronal death in acute ischemic stroke hypertension. 2015; 66:604-616.

20.zhang x, zhang p and li h*. interferon regulatory factor signalings in cardiometabolic diseases. hypertension. 2015; 66:222-247.


友情链接
环球app 环球app 环球app 环球app 环球app